Noh HM et al. |
Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice. |
2016 |
Korean J Gastroenterol |
pmid:27871162
|
Fan W et al. |
An unusual case of folliculitis spinulosa decalvans. |
2016 |
Cutis |
pmid:27814407
|
Miftahussurur M et al. |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. |
2016 |
BMC Microbiol. |
pmid:27809767
|
Sancak S et al. |
Intestinal blood flow by Doppler ultrasound: the impact of clarithromycin treatment for feeding intolerance in preterm neonates. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26135789
|
Uehara H et al. |
Comparison of the Anti-angiogenic and Anti-inflammatory Effects of Two Antibiotics: Clarithromycin Versus Moxifloxacin. |
2016 |
Curr. Eye Res. |
pmid:26125497
|
Ohe M et al. |
A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids. |
2016 |
Kaohsiung J. Med. Sci. |
pmid:27638410
|
Phaw NA and Tsai HH |
Eosinophilic gastroenteritis: a challenge to diagnose and treat. |
2016 |
BMJ Case Rep |
pmid:27613263
|
Plate A |
[Not Available]. |
2016 |
Praxis (Bern 1994) |
pmid:27606919
|
Huh CW et al. |
Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates. |
2016 |
PLoS ONE |
pmid:27588679
|
Watanabe M et al. |
Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal. |
2016 |
Int J Pharm |
pmid:27553780
|
Cosme A et al. |
Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance. |
2016 |
Helicobacter |
pmid:25982426
|
Campillo A et al. |
[Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection]. |
2016 |
Med Clin (Barc) |
pmid:27374029
|
Khashei R et al. |
High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. |
2016 |
APMIS |
pmid:27357065
|
Alarcón-Millán J et al. |
Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis. |
2016 |
Infect. Genet. Evol. |
pmid:27355861
|
Khonche A et al. |
Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial. |
2016 |
Drug Res (Stuttg) |
pmid:27351245
|
Büchsel M et al. |
A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia. |
2016 |
Diagn. Microbiol. Infect. Dis. |
pmid:27342785
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Abd-Elsalam S et al. |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. |
2016 |
Medicine (Baltimore) |
pmid:27310977
|
Oberhofer E |
[Quadruple therapy is more effective against H. pylori]. |
2016 |
MMW Fortschr Med |
pmid:27155683
|
Mayor S |
Short term increase in neuropsychiatric events is seen with H pylori treatment containing clarithromycin. |
2016 |
BMJ |
pmid:27143325
|
Shokri-Shirvani J et al. |
Letter: global emergence of Helicobacter pylori antibiotic resistance - unanswered questions. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137738
|
Wong AY et al. |
Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin. |
2016 |
JAMA Intern Med |
pmid:27136661
|
Zollner-Schwetz I et al. |
Primary resistance of Helicobacter pylori is still low in Southern Austria. |
2016 |
Int. J. Med. Microbiol. |
pmid:27134190
|
Georgopoulos SD et al. |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. |
2016 |
Eur. J. Intern. Med. |
pmid:27134145
|
Kim JS et al. |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. |
2016 |
Gut Liver |
pmid:27114421
|
Wong IC |
Author's reply to Blake. |
2016 |
BMJ |
pmid:26957514
|
Todo K et al. |
Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female. |
2016 |
Ann. Hematol. |
pmid:26957356
|
Iyer G and Alexander GC |
Editorialists' reply to Blake. |
2016 |
BMJ |
pmid:26957321
|
Blake Z |
Study provides insufficient evidence of a link between clarithromycin and myocardial infarction. |
2016 |
BMJ |
pmid:26955978
|
Seyama S et al. |
Clarithromycin Resistance Mechanisms of Epidemic β-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26953210
|
Ji Z et al. |
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China. |
2016 |
Medicine (Baltimore) |
pmid:26937912
|
Murakami K et al. |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. |
2016 |
Gut |
pmid:26935876
|
Park JY et al. |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. |
2016 |
Dig. Dis. Sci. |
pmid:26923948
|
Sun H et al. |
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014]. |
2016 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:26792053
|
Miglietta F et al. |
A rare case of Saprochaete capitata fungemia in a critical ill patient without hematologic and oncological disorders. |
2016 |
Rev Esp Quimioter |
pmid:26785226
|
Raymond J et al. |
Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. |
2016 |
Scand. J. Gastroenterol. |
pmid:26784882
|
Kefeli A et al. |
Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial. |
2016 |
Bosn J Basic Med Sci |
pmid:26773183
|
Iyer G and Alexander GC |
Cardiovascular risks associated with clarithromycin. |
2016 |
BMJ |
pmid:26769796
|
Wong AY et al. |
Cardiovascular outcomes associated with use of clarithromycin: population based study. |
2016 |
BMJ |
pmid:26768836
|
Jain SK et al. |
Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: a Novel Approach for Effective Treatment of H. pylori. |
2016 |
AAPS PharmSciTech |
pmid:26566630
|
Di Giulio M et al. |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. |
2016 |
Scand. J. Gastroenterol. |
pmid:26554617
|
Djennane-Hadibi F et al. |
High-Level Primary Clarithromycin Resistance of Helicobacter pylori in Algiers, Algeria: A Prospective Multicenter Molecular Study. |
2016 |
Microb. Drug Resist. |
pmid:26554340
|
Chen CH et al. |
Mycobacterium abscessus complex bacteremia due to prostatitis after prostate biopsy. |
2016 |
Indian J Tuberc |
pmid:27998503
|
Gehlot V et al. |
Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India. |
2016 |
J Glob Antimicrob Resist |
pmid:27530837
|
Xuan SH et al. |
Detection of clarithromycin-resistant Helicobacter pylori in clinical specimens by molecular methods: A review. |
2016 |
J Glob Antimicrob Resist |
pmid:27436390
|
Siddiqui TR et al. |
Emerging trends of antimicrobial resistance in Helicobacter pylori isolates obtained from Pakistani patients: The need for consideration of amoxicillin and clarithromycin. |
2016 |
J Pak Med Assoc |
pmid:27339574
|
Lee J et al. |
A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26441216
|
Shimizu T and Suzaki H |
Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan. |
2016 |
Auris Nasus Larynx |
pmid:26441370
|
Apostolopoulos P et al. |
Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study. |
2016 |
Scand. J. Gastroenterol. |
pmid:26435055
|
Hollitt A et al. |
Cat scratch disease of the parotid gland. |
2016 |
Arch. Dis. Child. |
pmid:26403943
|